Page: Viewing Company

Home Icon Home SEC Icon SEC
Create Alert

Viewing Company

Edit Company
Company Name: COLUCID PHARMACEUTICALS, INC.
CIK: 1348649
Phone: None
Fiscal Year End: None
Entity Type:
SIC: -
Category Type:
Entity Name: None
First Filing Date: 2015-06-18
Last Filing Date: 2016-11-09
SEC Filings
Start End Frame Filed ACCN Value View
2015-04-01 2015-06-30 CY2014Q2 2015-08-12 0001564590-15-007107 $ 9,546,074 View
2015-07-01 2015-09-30 CY2014Q3 2015-11-10 0001564590-15-010337 $ 15,153,135 View
2015-01-01 2015-03-31 CY2014Q1 2015-06-18 0001193125-15-227359 $ 144,301 View
2015-01-01 2015-12-31 CY2015 2016-03-24 0001564590-16-015194 $ 10,070,573 View
2016-01-01 2016-03-31 CY2016Q1 2016-05-11 0001564590-16-019098 $ 15,273,973 View
2016-04-01 2016-06-30 CY2016Q2 2016-08-10 0001564590-16-023823 $ 15,293,074 View
2016-07-01 2016-09-30 CY2016Q3 2016-11-09 0001564590-16-028478 $ 16,057,462 View
SEC Facts By Type
Type Name Description View
dei Entity Common Stock, Shares Outstanding Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. View
us-gaap Assets, Current Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Available-for-sale Securities, Noncurrent Investments in debt and equity securities which are categorized neither as held-to-maturity nor trading and which are intended to be sold or mature more than one year from the balance sheet date or operating cycle, if longer. Such securities are reported at fair value; unrealized gains (losses) related to Available-for-sale Securities are excluded from earnings and reported in a separate component of shareholders' equity (other comprehensive income), unless the Available-for-sale security is designated as a hedge or is determined to have had an other than temporary decline in fair value below its amortized cost basis. All or a portion of the unrealized holding gain (loss) of an Available-for-sale security that is designated as being hedged in a fair value hedge is recognized in earnings during the period of the hedge, as are other than temporary declines in fair value below the cost basis for investments in equity securities and debt securities that an entity intends to sell or it is more likely than not that it will be required to sell before the recovery of its amortized cost basis. Other than temporary declines in fair value below the cost basis for debt securities categorized as Available-for-sale that an entity does not intend to sell and for which it is not more likely than not that the entity will be required to sell before the recovery of its amortized cost basis are bifurcated into credit losses and losses related to all other factors. Other than temporary declines in fair value below cost basis related to credit losses are recognized in earnings, and losses related to all other factors are recognized in other comprehensive income. View
us-gaap Convertible Notes Payable, Current Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder. View
us-gaap Earnings Per Share, Basic and Diluted The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
us-gaap Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses. View
us-gaap Effective Income Tax Rate Reconciliation, Tax Credit, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits. View
us-gaap Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss. View
us-gaap Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. View
us-gaap Prepaid Expense, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. View
us-gaap Proceeds from Convertible Debt The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder. View
us-gaap Proceeds from Issuance of Common Stock The cash inflow from the additional capital contribution to the entity. View
us-gaap Proceeds from Sale and Maturity of Debt Securities, Available-for-sale Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). View
us-gaap Proceeds from Stock Options Exercised Amount of cash inflow from exercise of option under share-based payment arrangement. View
us-gaap Research and Development Expense The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. View
us-gaap Retained Earnings (Accumulated Deficit) The cumulative amount of the reporting entity's undistributed earnings or deficit. View
us-gaap Revenues Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). View
us-gaap Sales and Excise Tax Payable, Current Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Share-based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. View
us-gaap Weighted Average Number of Shares Outstanding, Basic and Diluted Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). View
dei Entity Public Float The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter. View
us-gaap Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Accrued Liabilities, Current Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Accrued Professional Fees, Current Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge. View
us-gaap Additional Paid in Capital Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. View
us-gaap Adjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation Amount of decrease in additional paid in capital (APIC) resulting from a tax deficiency associated with a share-based compensation plan other than an employee stock ownership plan (ESOP). View
us-gaap APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition Amount of increase in additional paid-in capital (APIC) for recognition of cost for employee stock purchase program (ESPP) award under share-based payment arrangement. View
us-gaap APIC, Share-based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. View
us-gaap Share-based Payment Arrangement, Expense Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. View
us-gaap Amortization of Debt Discount (Premium) Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense. View
us-gaap Assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Number of options outstanding, including both vested and non-vested options. View
us-gaap Available-for-sale Securities Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading. View
us-gaap Available-for-sale Securities, Accumulated Gross Unrealized Gain (Loss), before Tax Amount before tax of unrealized gain (loss) in accumulated other comprehensive income (AOCI) on investments in debt and equity securities classified as available-for-sale. View
us-gaap Available-for-sale Securities, Amortized Cost Basis This item represents the cost of debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any. View
us-gaap Available-for-sale Securities, Current Amount of investment in debt and equity securities categorized neither as trading securities nor held-to-maturity securities and intended be sold or mature one year or operating cycle, if longer. View
us-gaap Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Cash and Cash Equivalents, Fair Value Disclosure Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Cash and Cash Equivalents, Period Increase (Decrease) Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes. View
us-gaap Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock. View
us-gaap Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws. View
us-gaap Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. View
us-gaap Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. View
us-gaap Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. View
us-gaap Comprehensive Income (Loss), Net of Tax, Attributable to Parent Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. View
us-gaap Conversion of Stock, Amount Converted "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Current Foreign Tax Expense (Benefit) Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations. View
us-gaap Debt Conversion, Converted Instrument, Amount "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Debt Issuance Costs, Noncurrent, Net Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs. View
us-gaap Deferred Revenue, Noncurrent Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent. View
us-gaap Deferred Tax Assets, Charitable Contribution Carryforwards Amount before allocation of valuation allowances of deferred tax asset attributable to deductible charitable contribution carryforwards. View
us-gaap Deferred Tax Assets, Deferred Income Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income. View
us-gaap Deferred Tax Assets, Goodwill and Intangible Assets Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill. View
us-gaap Deferred Tax Assets, Operating Loss Carryforwards Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. View
us-gaap Deferred Tax Assets, Property, Plant and Equipment Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment. View
us-gaap Deferred Tax Assets, Tax Credit Carryforwards Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards. View
us-gaap Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation. View
us-gaap Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals. View
us-gaap Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities. View
us-gaap Deferred Tax Assets, Valuation Allowance, Current Amount of valuation allowance of deferred tax asset attributable to deductible temporary differences and carryforwards, classified as current. View
us-gaap Deferred Tax Assets, Valuation Allowance, Noncurrent Amount of valuation allowance of deferred tax asset attributable to deductible temporary differences and carryforwards, classified as noncurrent. View
us-gaap Defined Contribution Plan, Employer Discretionary Contribution Amount Amount of discretionary contributions made by an employer to a defined contribution plan. View
us-gaap Depreciation The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. View
us-gaap Effective Income Tax Rate Reconciliation, Percent Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. View
us-gaap Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Percentage of domestic federal statutory tax rate applicable to pretax income (loss). View
us-gaap Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets. View
us-gaap Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile. View
us-gaap Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments. View
us-gaap Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit). View
us-gaap Effective Income Tax Rate Reconciliation, Tax Credit, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits. View
us-gaap Employee-related Liabilities, Current Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Amount of cost not yet recognized for nonvested award under share-based payment arrangement. View
us-gaap Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. View
us-gaap Federal Income Tax Expense (Benefit), Continuing Operations Amount of current and deferred federal income tax expense (benefit) attributable to income (loss) from continuing operations. View
us-gaap General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. View
us-gaap Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. View
us-gaap Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. View
us-gaap Income Taxes Paid The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income. View
us-gaap Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. View
us-gaap Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit). View
us-gaap Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations. View
us-gaap Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses. View
us-gaap Effective Income Tax Rate Reconciliation, Other Adjustments, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments. View
us-gaap Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit). View
us-gaap Effective Income Tax Rate Reconciliation, Tax Contingency, State and Local, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in state and local income tax contingency. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. View
us-gaap Increase (Decrease) in Accounts Payable The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. View
us-gaap Increase (Decrease) in Accrued Liabilities The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. View
us-gaap Increase (Decrease) in Deferred Revenue Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable. View
us-gaap Increase (Decrease) in Other Operating Assets Amount of increase (decrease) in operating assets classified as other. View
us-gaap Increase (Decrease) in Prepaid Expense and Other Assets Amount of increase (decrease) in prepaid expenses, and assets classified as other. View
us-gaap Increase (Decrease) in Prepaid Expense The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods. View
us-gaap Increase in Carrying Amount of Redeemable Preferred Stock Adjustment to retained earnings for the increase in carrying amount of redeemable preferred stock that is classified as temporary equity. View
us-gaap Interest Expense Amount of the cost of borrowed funds accounted for as interest expense. View
us-gaap Investment Income, Interest Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. View
us-gaap Investments, Fair Value Disclosure Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method. View
us-gaap Liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. View
us-gaap Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. View
us-gaap Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. View
us-gaap Marketable Securities Amount of investment in marketable security. View
us-gaap Marketable Securities, Current Amount of investment in marketable security, classified as current. View
us-gaap Marketable Securities, Noncurrent Amount of investment in marketable security, classified as noncurrent. View
us-gaap Net Cash Provided by (Used in) Financing Activities, Continuing Operations Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. View
us-gaap Net Cash Provided by (Used in) Investing Activities, Continuing Operations Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. View
us-gaap Net Cash Provided by (Used in) Operating Activities, Continuing Operations Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. View
us-gaap Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. View
us-gaap Net Income (Loss) Available to Common Stockholders, Diluted Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders. View
us-gaap Nonoperating Income (Expense) The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). View
us-gaap Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. View
us-gaap Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues. View
us-gaap Other Accrued Liabilities, Current Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer. View
us-gaap Other Assets, Noncurrent Amount of noncurrent assets classified as other. View
us-gaap Other Comprehensive Income (Loss), Net of Tax Amount after tax and reclassification adjustments of other comprehensive income (loss). View
us-gaap OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. View
us-gaap Payments of Financing Costs The cash outflow for loan and debt issuance costs. View
us-gaap Payment, Tax Withholding, Share-based Payment Arrangement Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement. View
us-gaap Payments to Acquire Available-for-sale Securities The cash outflow to acquire debt and equity securities not classified as either held-to-maturity securities or trading securities which would be classified as available-for-sale securities and reported at fair value, with unrealized gains and losses excluded from earnings and reported in a separate component of shareholders' equity. View
us-gaap Payments to Acquire Marketable Securities Amount of cash outflow for purchase of marketable security. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Gross number of share options (or share units) granted during the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted average price at which option holders acquired shares when converting their stock options into shares. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. View
us-gaap Share-based Payment Arrangement, Expensed and Capitalized, Amount Amount of cost expensed and capitalized for award under share-based payment arrangement. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. View
us-gaap Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement. View
us-gaap State and Local Income Tax Expense (Benefit), Continuing Operations Amount of state and local current and deferred income tax expense (benefit) attributable to continuing operations. View
us-gaap Stockholders' Equity Attributable to Parent Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. View
us-gaap Stock Issued During Period, Shares, Conversion of Convertible Securities Number of shares issued during the period as a result of the conversion of convertible securities. View
us-gaap Stock Issued During Period, Shares, Restricted Stock Award, Gross Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Number of share options (or share units) exercised during the current period. View
us-gaap Stock Issued During Period, Value, New Issues Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. View
us-gaap Stock Issued During Period, Value, Stock Options Exercised Value of stock issued as a result of the exercise of stock options. View
us-gaap Temporary Equity, Accretion to Redemption Value, Adjustment Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders. View
us-gaap Unrecognized Tax Benefits Amount of unrecognized tax benefits. View
us-gaap Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return. View
us-gaap Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return. View
us-gaap Unrecognized Tax Benefits, Period Increase (Decrease) Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns. View
us-gaap Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. View
Chart of Accounts => Accounts
Name View
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount View
Payments to Acquire Marketable Securities View
Prepaid Expense and Other Assets, Current View
Prepaid Expense, Current View
Proceeds from Convertible Debt View
Proceeds from Issuance of Common Stock View
Proceeds from Sale and Maturity of Debt Securities, Available-for-sale View
Proceeds from Stock Options Exercised View
Research and Development Expense View
Retained Earnings (Accumulated Deficit) View
Revenues View
Sales and Excise Tax Payable, Current View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period View
Accounts Payable, Current View
Accrued Liabilities, Current View
Accrued Professional Fees, Current View
Accumulated Other Comprehensive Income (Loss), Net of Tax View
Additional Paid in Capital View
Adjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation View
APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition View
APIC, Share-based Payment Arrangement, Increase for Cost Recognition View
Share-based Payment Arrangement, Expense View
Amortization of Debt Discount (Premium) View
Assets View
Assets, Current View
Available-for-sale Securities View
Available-for-sale Securities, Accumulated Gross Unrealized Gain (Loss), before Tax View
Available-for-sale Securities, Amortized Cost Basis View
Available-for-sale Securities, Current View
Available-for-sale Securities, Noncurrent View
Cash and Cash Equivalents, at Carrying Value View
Cash and Cash Equivalents, Fair Value Disclosure View
Cash and Cash Equivalents, Period Increase (Decrease) View
Common Stock, Par or Stated Value Per Share View
Common Stock, Shares Authorized View
Common Stock, Shares, Issued View
Common Stock, Shares, Outstanding View
Common Stock, Value, Issued View
Comprehensive Income (Loss), Net of Tax, Attributable to Parent View
Conversion of Stock, Amount Converted View
Convertible Notes Payable, Current View
Current Foreign Tax Expense (Benefit) View
Debt Conversion, Converted Instrument, Amount View
Debt Issuance Costs, Noncurrent, Net View
Deferred Revenue, Noncurrent View
Deferred Tax Assets, Charitable Contribution Carryforwards View
Deferred Tax Assets, Deferred Income View
Deferred Tax Assets, Goodwill and Intangible Assets View
Deferred Tax Assets, Operating Loss Carryforwards View
Deferred Tax Assets, Property, Plant and Equipment View
Deferred Tax Assets, Tax Credit Carryforwards View
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost View
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals View
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities View
Deferred Tax Assets, Valuation Allowance, Current View
Deferred Tax Assets, Valuation Allowance, Noncurrent View
Defined Contribution Plan, Employer Discretionary Contribution Amount View
Depreciation View
Earnings Per Share, Basic and Diluted View
Effective Income Tax Rate Reconciliation, Percent View
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent View
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent View
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent View
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent View
Effective Income Tax Rate Reconciliation, Other Adjustments, Percent View
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent View
Effective Income Tax Rate Reconciliation, Tax Credit, Percent View
Employee-related Liabilities, Current View
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases View
Federal Income Tax Expense (Benefit), Continuing Operations View
General and Administrative Expense View
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest View
Income Tax Expense (Benefit) View
Income Taxes Paid View
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount View
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount View
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount View
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount View
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount View
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount View
Effective Income Tax Rate Reconciliation, Tax Contingency, State and Local, Amount View
Effective Income Tax Rate Reconciliation, Tax Credit, Amount View
Increase (Decrease) in Accounts Payable View
Increase (Decrease) in Accrued Liabilities View
Increase (Decrease) in Deferred Revenue View
Increase (Decrease) in Other Operating Assets View
Increase (Decrease) in Prepaid Expense and Other Assets View
Increase (Decrease) in Prepaid Expense View
Increase in Carrying Amount of Redeemable Preferred Stock View
Interest Expense View
Investment Income, Interest View
Investments, Fair Value Disclosure View
Liabilities View
Liabilities and Equity View
Liabilities, Current View
Marketable Securities View
Marketable Securities, Current View
Marketable Securities, Noncurrent View
Net Cash Provided by (Used in) Financing Activities, Continuing Operations View
Net Cash Provided by (Used in) Investing Activities, Continuing Operations View
Net Cash Provided by (Used in) Operating Activities, Continuing Operations View
Net Income (Loss) Attributable to Parent View
Net Income (Loss) Available to Common Stockholders, Diluted View
Nonoperating Income (Expense) View
Operating Expenses View
Operating Income (Loss) View
Other Accrued Liabilities, Current View
Other Assets, Noncurrent View
Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent View
Other Comprehensive Income (Loss), Net of Tax View
OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax View
Payments of Financing Costs View
Payment, Tax Withholding, Share-based Payment Arrangement View
Payments to Acquire Available-for-sale Securities View
Share-based Payment Arrangement, Noncash Expense View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price View
Share-based Payment Arrangement, Expensed and Capitalized, Amount View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value View
Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation View
State and Local Income Tax Expense (Benefit), Continuing Operations View
Stockholders' Equity Attributable to Parent View
Stock Issued During Period, Shares, Conversion of Convertible Securities View
Stock Issued During Period, Shares, Restricted Stock Award, Gross View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period View
Stock Issued During Period, Value, New Issues View
Stock Issued During Period, Value, Stock Options Exercised View
Temporary Equity, Accretion to Redemption Value, Adjustment View
Unrecognized Tax Benefits View
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued View
Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions View
Unrecognized Tax Benefits, Period Increase (Decrease) View
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount View
Weighted Average Number of Shares Outstanding, Basic and Diluted View